Saliva that fights norovirus? Experimental oral vaccine is nothing to spit at.

Research identifies key antibodies for development of broadly protective norovirus vaccine

Scientists have discovered a strategy to fight back against norovirus, a leading cause of gastroenteritis worldwide. Their new study identifies powerful antibodies capable of neutralizing a wide range of norovirus strains. The finding could lead to the design of broadly effective norovirus vaccine, as well as the development of new therapeutic antibodies for the treatment of norovirus-associated gastroenteritis.

Saliva that fights norovirus? Experimental oral vaccine is nothing to spit at.

Phase I study showed vaccine was safe and spurred immune responses in older people.

New norovirus vaccine pill could protect against the horror vomiting bug

WHILE norovirus still circulates at high levels, a new pill designed to protect against the winter vomiting bug has been undergoing trials. Just two weeks ago there was a record number of patients in hospital with norovirus in England. GettyA new norovirus vaccine pill is in the works that’s been shown to offer protection in older people[/caption] GettyNorovirus hospitalisations have been much higher this year[/caption] Data from NHS England sho…

Norovirus vaccine pill shows promise against 'winter vomiting' bug

Most people recover from norovirus, a highly contagious infection, within a few days but it can be particularly risky for some groups. Now a small trial of a pill designed to protect against the virus has shown promise in older people

National norovirus and rotavirus surveillance reports: 2024 to 2025 season

Reports of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in hospital and community settings in England during the 2024 to 2025 season.

Researchers have developed and tested two new vaccine candidates against the notorious noroviruses. The two vaccines in tablet form stimulate the formation of antibodies against the diarrhea pathogens. In the first tests, one of these vaccine candidates proved to be particularly effective and compatible for the elderly. The second vaccine showed a particularly broad effect against different virus variants. Based on these active substances, new n…